Purple Innovation, Inc. PRPL
Set alert
2.40 USD -0.47 -16.38%
As of Nov 3, 11:37 AM ET
2.38 Day range 2.87
1.83 52-week range 21.75
- YTD
- -86.10%
- 1 year
- -87.95%
- Open
- 2.86
- Prev close
- 2.87
- Mkt cap
- 10.61M
- Vol
- 9.53K
- Avg vol
- 35.67K
- EPS
- -11.27
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.38
- High
- 2.87
- Forward P/E
- -2.88
- Beta
- 2.08
- Short ratio
- 9.60
- Inst. own
- 74.70%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.90752
- 200-d avg
- 1.20
- 1y target
- 1.98
Analyst view
Consensus: hold
Hold
Price target (mean) 1.98 -17.5% downside
Now 2.40
- Target (low)
- 0.90
- Target (mean)
- 1.98
- Target (high)
- 5.00
Ratings (0m) 8 2 buy · 6 hold · 0 sell
- Strong buy1
- Buy1
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 8
- 1 month ago 8
- 2 months ago 8
- 3 months ago 8
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.07571 | -0.12 – -0.04 | -0.15 | +49.5% | 130.60M | -10.5% | 7 |
| Next quarter | -0.10 | -0.12 – -0.07 | -0.19 | +47.4% | 117.53M | -2.1% | 5 |
| Current year | -0.47571 | -0.51 – -0.44 | -0.70 | +32.0% | 489.50M | -4.1% | 7 |
| Next year | -0.30571 | -0.42 – -0.22 | -0.47571 | +35.7% | 499.96M | +2.1% | 7 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 4, 2024 | Wedbush | Downgrade | Outperform | Neutral |
| Aug 6, 2024 | Craig-Hallum | Maintained | Hold | Hold |
| May 8, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Mar 21, 2024 | Roth MKM | Reiterated | Buy | Buy |
| Mar 13, 2024 | Roth MKM | Upgrade | Neutral | Buy |
| Mar 13, 2024 | Craig-Hallum | Maintained | Hold | Hold |
| Mar 13, 2024 | Wedbush | Maintained | Outperform | Outperform |
| Mar 7, 2024 | Roth MKM | Maintained | Neutral | Neutral |
| Jan 24, 2024 | Wedbush | Reiterated | Outperform | Outperform |
| Jan 24, 2024 | Keybanc | Maintained | Overweight | Overweight |
| Nov 13, 2023 | Oppenheimer | Downgrade | Outperform | Perform |
| Nov 10, 2023 | Craig-Hallum | Downgrade | Buy | Hold |
| Nov 10, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Nov 10, 2023 | Keybanc | Maintained | Overweight | Overweight |
| Aug 25, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Aug 10, 2023 | Wedbush | Maintained | Outperform | Outperform |
| Apr 14, 2023 | Wedbush | Reiterated | — | Outperform |
| Mar 21, 2023 | UBS | Maintained | — | Neutral |
| Feb 1, 2023 | Keybanc | Maintained | — | Overweight |
| Jan 12, 2023 | Keybanc | Maintained | — | Overweight |
| Nov 10, 2022 | Craig-Hallum | Upgrade | Hold | Buy |
| Sep 20, 2022 | Wedbush | Maintained | — | Outperform |
| Sep 20, 2022 | Keybanc | Maintained | — | Overweight |
| Mar 28, 2022 | Keybanc | Maintained | — | Overweight |
| Mar 2, 2022 | Roth Capital | Downgrade | Buy | Neutral |
| Mar 2, 2022 | Keybanc | Maintained | — | Overweight |
| Dec 14, 2021 | Wedbush | Maintained | — | Outperform |
| Dec 14, 2021 | Keybanc | Maintained | — | Overweight |
| Nov 10, 2021 | UBS | Downgrade | Buy | Neutral |
| Nov 10, 2021 | Truist Securities | Downgrade | Buy | Hold |